Malin Almgren

Malin Almgren is a seasoned professional with extensive experience in the healthcare and research sectors. Currently, Almgren serves as a Board Member for CombiGene, Redsense Medical, and Experia Nordic Oy, alongside a role as Advisory Board Member at Experia Corporate Finance Advisors. As Chief Executive Officer at Schain Research, Almgren leads efforts in health data sciences and real-world evidence to enhance drug development and patient outcomes. Previous roles include Board Member at DP Services AB, conducting clinical research at Karolinska Institutet, and leading strategic partnerships at Tundra Research Network and Tundra Fonder AB. Almgren holds a PhD in Medicine from Karolinska Institutet and an MSc in Chemistry from Stockholm University.